{"nct_id":"NCT02972034","title":"Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2017-01-13","start_date_type":"ACTUAL","primary_completion_date":"2022-12-02","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-02","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}